Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Dutasteride is becoming a popular hair loss treatment, proving more effective than finasteride with similar side effects.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

A new antiandrogen compound was made and its detailed three-dimensional shape was described.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

Dutasteride may become the top choice for treating hair loss.

Sex steroids, especially progesterone, can slow down the growth of mouse melanoma cells.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

El acetato de ciproterona trata problemas androgénicos como hirsutismo, acné, seborrea y alopecia con diferentes dosis y combinaciones.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Spironolactone may help reduce hair loss in androgenic alopecia.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

Finasteride weakens the bone-protective effects of certain blockers in low androgen conditions.

Finasteride effectively treats male pattern baldness.

A woman experienced hair loss, nail changes, bone marrow suppression, and low blood protein after taking azathioprine.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.